Susquehanna International Group
NAMSW icon

Susquehanna International Group’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Susquehanna International Group’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,319
Closed -$57.3K – 12928
2023
Q4 		$57.3K Buy
+18,319
New +$35.9K ﹤0.01% 11663

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Susquehanna International Group's NAMSW Position: Q1 2024 in Review

Susquehanna International Group sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 18,319 shares — an estimated $57.3K sold.

Susquehanna International Group first reported a position in NAMSW in Q4 2023 and held it in 1 quarter. The position peaked at $57.3K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • Susquehanna International Group reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 18,319 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $57.3K.
  • Susquehanna International Group first reported a position in NewAmsterdam Pharma Warrant in Q4 2023 and held it in 1 quarter.
  • Susquehanna International Group's NewAmsterdam Pharma Warrant position peaked at $57.3K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.